The Latest Cardiac and Vascular News
HINGHAM, Mass., April 23, 2019 (GLOBE NEWSWIRE) — As it continues to receive an overwhelming positive response from global jurisdictions, Microbot Medical Inc. (NASDAQ: MBOT) expands its IP portfolio as it receives a Notice of Allowance from the Canadian Intellectual […]
HINGHAM, Mass., March 04, 2019 (GLOBE NEWSWIRE) — Further expanding its global IP portfolio, Microbot Medical Inc. (Nasdaq CM: MBOT) received an official communication from the European Patent Office regarding its intention to grant European Patent Application No. 13 746 […]
HINGHAM, Mass., June 18, 2018 (GLOBE NEWSWIRE) — Microbot Medical Inc. (Nasdaq CM:MBOT), a medical device company specializing in the design and development of transformational micro-robotic medical technologies, today announced that the European Patent Office (EPO) has notified the Company […]
